“…One pathway exclusively found from the BD‐NC analysis was “axonal guidance signaling.” Neurons extend axons to reach target cells and form functional circuits during development, and dysregulation of axon guiding can result in deficits in neural circuit formation. This is consistent with other previous studies; a meta‐analysis studying potential cardiometabolic mood disorder genes (Amare, Schubert, Klingler‐Hoffmann, Cohen‐Woods, & Baune, ), a microRNA BD study (Shih, Kao, Chuang, & Kuo, ), a genetic family‐wide BD study (Xu et al, ), and a BD/schizophrenia methylation study (Xiao et al, ), which all found an association between BD and axonal guidance signaling. Furthermore, lithium, a common medication for BD, increases axonal spreading (Lucas, Goold, Gordon‐Weeks, & Salinas, ), and the Wnt signaling pathway, which is activated by lithium (Klein & Melton, ), also regulates axon guidance (Garcia, Udeh, Kalahasty, & Hackam, ).…”